1048 related articles for article (PubMed ID: 18281693)
1. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
Rodríguez Guardado A; Blanco A; Asensi V; Pérez F; Rial JC; Pintado V; Bustillo E; Lantero M; Tenza E; Alvarez M; Maradona JA; Cartón JA
J Antimicrob Chemother; 2008 Apr; 61(4):908-13. PubMed ID: 18281693
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
3. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for Acinetobacter baumannii infections.
Vila J; Pachón J
Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
[TBL] [Abstract][Full Text] [Related]
7. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C
J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
[TBL] [Abstract][Full Text] [Related]
9. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
[TBL] [Abstract][Full Text] [Related]
10. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas.
Paramythiotou E; Karakitsos D; Aggelopoulou H; Sioutos P; Samonis G; Karabinis A
Med Mal Infect; 2007 Feb; 37(2):124-5. PubMed ID: 17270377
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
Saçar S; Turgut H; Cenger DH; Coşkun E; Asan A; Kaleli I
J Infect Dev Ctries; 2007 Dec; 1(3):342-4. PubMed ID: 19734617
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
[TBL] [Abstract][Full Text] [Related]
14. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.
Ng J; Gosbell IB; Kelly JA; Boyle MJ; Ferguson JK
J Antimicrob Chemother; 2006 Nov; 58(5):1078-81. PubMed ID: 16916866
[TBL] [Abstract][Full Text] [Related]
15. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.
Jain R; Danziger LH
Ann Pharmacother; 2004 Sep; 38(9):1449-59. PubMed ID: 15280512
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
19. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
20. Postsurgical meningitis caused by Acinetobacter baumannii associated with high mortality.
Huttova M; Freybergh PF; Rudinsky B; Sramka M; Kisac P; Bauer F; Ondrusova A
Neuro Endocrinol Lett; 2007 Jun; 28 Suppl 2():15-6. PubMed ID: 17558367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]